COMPARISON OF DIFFERENT DOSES OF INTRATHECAL NALBUPHINE AS AN ADJUVANT TO 0.5% HYPERBARIC BUPIVACAINE IN SUB-ARACHNOID BLOCK IN LOWER ABDOMEN AND LOWER LIMB SURGERIES

Dr Tavleen Kaur Brar0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年2月21日

试验速览

暂无简介。

•1. Age between 18 to 60 years of either gender.
•2. ASA grade I and II.
•3. Patients posted for elective lower abdomen and lower limb surgeries under spinal anaesthesia.
•4. Weight of the patient being in normal range for that age and sex.
•5. Patients who are not on any antihypertensive, anti-platelet, fibrinolytic or anticoagulant drugs.
•6. Haemodynamically stable patients with normal laboratory investigations.
•7. Patients who give informed consent and are willing to be a part of the study.

•1. Patients with pre-existing cardiovascular diseases (IHD, hypertension, valvular heart disease), deranged liver functions or renal functions.
•2. Patients with any neurological or psychiatric disorders.
•3. Patients with any contraindications for neuraxial block.
•4. Patients posted for emergency procedures
•5. History of allergy to any of the drugs being used under study
•6. Unwilling patients.

发起方

Dr Tavleen Kaur Brar